GGrantIndex
Sort

59,101 grants matching hypertension

HYPERTENSION IN POPULATIONS OF WEST AFRICAN ORIGIN

$472,097
Loyola University Chicago · R37 · FY2005 · HL

Role of Gs-alpha in central regulation of energy and glucose metabolism

$472,084
Lee Weinstein · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK

GENETIC AND ENVIRONMENTAL RISK FACTORS FOR STROKE

$472,044
University Of Cincinnati · R01 · FY2000 · NS

Role of mitochondrial microRNAs (mitomiRs) in endogenous renal repair

$472,014
Alfonso Eirin · Mayo Clinic Rochester · R01 · FY2023 · DK

Purines and the health of retinal ganglion cells

$471,999
Claire H Mitchell · University Of Pennsylvania · R01 · FY2019 · EY

Liver Pathobiology: insights through the lens of rare diseases

$471,988
Silvia Vilarinho · Yale University · R01 · FY2024 · DK

AngII-Salt Hypertension Increases Respiratory-Vasomotor Neuron Coupling in RVLM

$471,976
Glenn M Toney · University Of Texas Hlth Science Center · R01 · FY2011 · HL

Monocyte P311 Expression Level as Predictor of Hypertension in Mice

$471,920
Lucia Schuger · University Of Chicago · RC1 · FY2010 · HL

Signal transduction mechanisms that mediate normal and pathologic angiogenesis

$471,903
Jinjiang Pang · University Of Rochester · R01 · FY2023 · HL

Optimizing Display of Blood Pressure Data to Support Clinical Decision Making

$471,895
Richelle J Koopman · University Of Missouri-Columbia · R01 · FY2019 · HS

Home Blood Pressure Outcomes Evaluation Study (HOMESTEAD)

$471,886
Paul Englund Drawz · University Of Minnesota · R01 · FY2023 · HL

MULTICENTER NETWORK OF MATERNAL-FETAL MEDICINE UNITS

$471,837
Magee-Women'S Res Inst And Foundation · U10 · FY2005 · HD

Alleviating Opioid-Induced Hyperalgesia with Novel Pharmacotherapy

$471,814
Jianren Mao · Massachusetts General Hospital · R01 · FY2015 · DA

Vascular smooth muscle NAD(P)H oxidases

$471,778
Kathy K Griendling · Emory University · P01 · FY2007 · HL

Launching a salt substitute to reduce blood pressure at the population level-Peru

$471,727
Robert H Gilman · Johns Hopkins University · U01 · FY2014 · HL

Randomized Trial of Stepped Palliative Care versus Early Integrated Palliative Care in Patients with Advanced Lung Cancer

$471,698
Jennifer Temel · Massachusetts General Hospital · R01 · FY2022 · CA

Using Precision Performance Measurement to Conduct Focused Quality Improvement

$471,686
David W. Baker · Northwestern University At Chicago · R18 · FY2007 · HS

Novel Mechanism Regulating RAS Activity in the Brain: Role in Neurogenic Hypertension

$471,678
Curt Daniel Sigmund · University Of Iowa · P01 · FY2018 · HL

Bioenergetic and Metabolic Consequences of the Loss of Ovarian Function in Women

$471,650
Wendy M Kohrt · University Of Colorado Denver · P50 · FY2013 · HD

Early Life Precusors of Chronic Disease

$471,636
Carolyn T Halpern · Univ Of North Carolina Chapel Hill · P01 · FY2016 · HD

Functional Evaluation of CDH Patient Gene Variants in Vitro and in Select Animal Models

$471,612
Mauro Longoni · Massachusetts General Hospital · P01 · FY2021 · HD

Biomarkers for White Matter Injury in Mixed and Vascular Cognitive Impairment

$471,531
Gary Allen Rosenberg · University Of New Mexico Health Scis Ctr · R01 · FY2013 · NS

Intermittent Hypoxia-Induced Hypertension: Roles of Angiotensin and Chloride Transport in the Lamina Terminalis.

$471,488
J Thomas Cunningham · University Of North Texas Hlth Sci Ctr · P01 · FY2015 · HL

RCHDR Administrative Core

$471,453
Deepak Kumar · North Carolina Central University · U54 · FY2017 · MD

APJ receptor agonism for metabolic syndrome

$471,450
Rangan Maitra · Research Triangle Institute · R01 · FY2017 · DK